HeartGuardAI

Elevator Pitch: HeartGuardAI revolutionizes heart attack diagnostics with AI, catching life-threatening occlusions early by analyzing ECGs with unparalleled accuracy. Our technology means faster, life-saving treatment interventions, making it an essential upgrade for every health provider’s toolkit.

Concept

AI-powered ECG analysis for early detection of occlusive myocardial infarction

Objective

To enhance the accuracy and speed of OMI detection using ECG data through an advanced AI algorithm.

Solution

Utilize ECG-SMART-NET, a modified ResNet-18 architecture capable of learning complex temporal and spatial features from ECG data, to identify difficult-to-detect OMI cases.

Revenue Model

Subscription-based service for healthcare providers and possible licensing of the technology to medical device manufacturers.

Target Market

Hospitals, clinics, emergency medical services, and medical device companies worldwide.

Expansion Plan

Start with major hospitals in urban areas, expand to smaller clinics and rural settings, and eventually integrate with consumer health monitoring devices.

Potential Challenges

Integration challenges with existing ECG machines and healthcare IT systems, securing approval from medical regulatory bodies, data privacy concerns.

Customer Problem

Early and accurate detection of OMI, which is a critical condition requiring immediate intervention but hard to diagnose visually.

Regulatory and Ethical Issues

Must comply with healthcare regulations such as HIPAA in the US, GDPR in Europe, and others depending on the region. Ethical considerations around data privacy and AI decision-making in healthcare.

Disruptiveness

Improves diagnostic accuracy and can reduce time-to-treatment for heart attack patients, likely lowering mortality rates and improving outcomes.